Article
Association Between Mutation Clearance After Induction Therapy and Outcomes in Acute Myeloid Leukemia.
JAMA - 25 Aug 2015
Klco Jeffery M, Miller Christopher A, Griffith Malachi, Petti Allegra, Spencer David H, Ketkar-Kulkarni Shamika, Wartman Lukas D, Christopher Matthew, Lamprecht Tamara L, Helton Nicole M, Duncavage Eric J, Payton Jacqueline E, Baty Jack, Heath Sharon E, Griffith Obi L, Shen Dong, Hundal Jasreet, Chang Gue Su, Fulton Robert, O'Laughlin Michelle, Fronick Catrina, Magrini Vincent, Demeter Ryan T, Larson David E, Kulkarni Shashikant, Ozenberger Bradley A, Welch John S, Walter Matthew J, Graubert Timothy A, Westervelt Peter, Radich Jerald P, Link Daniel C, Mardis Elaine R, DiPersio John F, Wilson Richard K, Ley Timothy J
Abstract excerpt
IMPORTANCE: Tests that predict outcomes for patients with acute myeloid leukemia (AML) are imprecise, especially for those with intermediate risk AML. OBJECTIVES: To determine whether genomic approaches can provide novel prognostic information for adult patients with de novo AML. DESIGN, SETTING, AND PARTICIPANTS: Whole-genome or exome sequencing was performed on samples obtained at disease presentation from 71...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
